Perspective Therapeutics

CATXNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$342.139 M

$3.00 +1.01%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$103.1M

Loss-making

Shares outstanding

113,933,436

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#229Foghorn TherapeuticsFHTX$356.4M
#230Galectin TherapeuticsGALT$347.9M
#231Perspective TherapeuticsCATX$342.1M
#232Turn TherapeuticsTTRX$310.1M
#233Amarin Corp Plc\UkAMRN$303.3M

Where these numbers come from

Share counts and financials for Perspective Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.